Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/1996
05/23/1996WO1996015234A2 Lipid-splitting enzyme
05/23/1996WO1996014868A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids
05/23/1996WO1996014857A1 Multicatalytic protease inhibitors
05/23/1996WO1996014852A1 Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna)
05/23/1996WO1996014839A1 Pharmaceutical composition comprising non-steroidal anti-inflammatory drugs
05/23/1996WO1996009827A3 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor
05/23/1996CA2204908A1 Lipid cleavage enzyme
05/23/1996CA2204145A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids
05/23/1996CA2202760A1 Multicatalytic protease inhibitors
05/22/1996EP0713092A1 Method to detect factors in a model of paralysis and method to obtain this model
05/22/1996EP0712629A1 Acyl deoxyribonucleoside derivatives and uses thereof
05/22/1996EP0712583A2 Total parenteral nutrition solution containing watersoluble vitamin B
05/22/1996EP0712312A1 Suppression of inhibitors
05/22/1996EP0486526B1 Tumour necrosis factor binding ligands
05/22/1996CN1123005A Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid
05/21/1996US5519061 Monoamine oxidase inhibitors, parkinson's disease
05/21/1996US5519021 Benzoxazinones as inhibitors of HIV reverse transcriptase
05/21/1996US5518725 Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
05/17/1996WO1996014411A1 Methods for the diagnosis of glaucoma
05/17/1996WO1996014399A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease
05/17/1996WO1996014398A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996WO1996014328A1 Tumor necrosis factor-gamma
05/17/1996WO1996014077A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
05/17/1996WO1996014071A1 Combination of chemical compounds used as a medicament intended to suppress the dependence of individuals to opioids
05/17/1996WO1996010419A3 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
05/17/1996CA2204429A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease
05/17/1996CA2204427A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/15/1996EP0711167A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict
05/15/1996EP0493408B1 Oral anticoagulant/platelet inhibitor low dose formulation
05/15/1996EP0465565B1 Treatment of aids dementia, myelopathy and blindness
05/15/1996CN1122248A Insulin analog formulations
05/14/1996US5516905 Enzyme inhibitors of dna polymerase for bactericides
05/14/1996US5516887 Luteinizing hormone releasing hormone antagonist peptides
05/14/1996US5516798 Administering a methylamine
05/14/1996US5516793 Use of ascorbic acid to reduce irritation of topically applied active ingredients
05/14/1996US5516781 Method of treating restenosis with rapamycin
05/14/1996US5516673 Preactivation of cellulose, polyvinyl alcohol, or the like with pyridine, pyrrole, pyridazine or their derivatives; further reaction with proteins; wound healing agents
05/14/1996US5516653 Genetic engineering
05/14/1996US5516535 Beverage compositions having enhanced β-carotene bioavailability
05/09/1996WO1996013518A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
05/09/1996WO1996013257A1 Use of receptor potentiators
05/09/1996WO1996013226A1 Method for the treatment of periodontal disease and a pharmaceutical composition useful in said method
05/09/1996WO1996013179A2 Nutrient supplement compositions providing physiologic feedback
05/09/1996CA2204154A1 Nutrient supplement compositions providing physiologic feedback
05/09/1996CA2200886A1 Use of ner receptors potentiators
05/08/1996EP0710479A1 Use of a serotonin agonist in combination with a tachykinin receptor antagonist for the manufacture of a medicament for the treatment or prevention of migraine
05/08/1996EP0710281A1 A method of producing a protein disulfide redox agent
05/08/1996EP0710116A1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
05/08/1996EP0710112A1 Use of vitamin D and derivatives thereof for the manufacture of a medicament for protection against neuron loss
05/08/1996EP0710109A1 Compounds
05/08/1996EP0710106A1 Method of treating addictive behaviors
05/08/1996EP0710105A1 Synergistic anthelmintic compositions
05/08/1996CN1122105A Treatment of tumors with compounds having RXR retinoid receptor agonist activity
05/08/1996CN1122104A Gaba-Ergic modulation of eye growth
05/08/1996CA2159851A1 Combination of a potassium channel activator and a biguanide non-sulfonylurea agent
05/07/1996US5514680 Glycine receptor antagonists and the use thereof
05/07/1996US5514660 Method for treating and inhibiting gastric and duodenal ulcers
05/07/1996US5514382 Daily vitamin and mineral supplement for women
05/07/1996US5513661 Use of sympathetic blockade for treatment of chronic muscle pain
05/07/1996CA2075551C Treatment of periodontitis
05/02/1996WO1996012817A1 Combination method for acne treatment
05/02/1996WO1996012791A1 Human abh
05/02/1996WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996WO1996012741A1 Binding agents to cd23
05/02/1996WO1996012735A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding
05/02/1996WO1996012501A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2
05/02/1996WO1996012487A1 Combination method for acne treatment
05/02/1996WO1996012479A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs
05/02/1996WO1996012475A1 Active agent transport systems
05/02/1996WO1996012470A1 Treatment of pulmonary conditions associated with insufficient secretion of surfactant
05/02/1996WO1996012406A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
05/02/1996WO1996003151A3 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
05/02/1996WO1995034571A3 Drug salts
05/02/1996CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996CA2203363A1 Binding agents to cd23
05/02/1996CA2203271A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs
05/02/1996CA2203118A1 Treatment of pulmonary conditions associated with insufficient secretion of surfactant
05/02/1996CA2200869A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
05/02/1996CA2199980A1 Combination method for acne treatment
05/02/1996CA2199979A1 Combination method for acne treatment
05/01/1996EP0709098A1 Compositions containing piperine
05/01/1996EP0709090A2 Compositions for treating resistant tumors
05/01/1996EP0708660A1 Prodrugs of protein tyrosine kinase inhibitors
05/01/1996EP0708653A1 Assay and reagents for identifying anti-proliferative agents
05/01/1996CN1121412A Compositions containing piperine
04/1996
04/30/1996US5512580 Method and compositions for maintaining glomerular filtration rate while inhibiting extracellular matrix accumulation
04/30/1996US5512578 Administering bimodally-acting opioid agonist and excitatory opioid receptor antagonist
04/30/1996US5512555 Administering a composition containing 5 alpha-reductase inhibitors and antiperspirant
04/30/1996US5512284 Method for treating bacterial infections
04/30/1996US5512269 Method of treating retained pulmonary secretions
04/30/1996US5512200 Low pH Acidic Compositions
04/25/1996WO1996012184A1 Diagnosis and monitoring process, and medicaments for the therapy of states of shock in human beings
04/25/1996WO1996011712A2 Cell-specific gene delivery vehicles
04/25/1996WO1996011710A1 External preparation for nail ringworm
04/25/1996WO1996011706A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation
04/25/1996WO1996011693A1 Dermatosis remedy
04/25/1996WO1996011689A1 Use of cck-b receptor antagonists for the treatment of sleep disorders
04/25/1996WO1996011681A1 Preventive and remedy for diarrhea
04/25/1996WO1996011677A1 Methods for treating resistant tumors
04/25/1996WO1996011676A1 Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
1 ... 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 ... 1151